Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain
Clinical trial NCT03564548 · UNKNOWN
Trial details
- NCT number
- NCT03564548
- Sponsor
- Tetra Bio-Pharma
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-26
- Primary completion
- 2022-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.